Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival

被引：0
|
作者：
Ying Zhang
Yajie Ji
Jianwei Li
Li Lei
Siyu Wu
Wenjia Zuo
Xiaoqing Jia
Yujie Wang
Miao Mo
Na Zhang
Zhenzhou Shen
Jiong Wu
Zhimin Shao
Guangyu Liu
机构：
[1] Fudan University Shanghai Cancer Center,Department of Breast Surgery
[2] Shanghai Medical College,Department of Oncology
[3] Fudan University,Department of Breast Surgery
[4] Yueyang Hospital of Integrated Chinese and Western Medicine,Department of Breast Surgery
[5] Shanghai University of Traditional Chinese Medicine,Clinical Statistics Center
[6] Calmete Affiliated Hospital of Kunming Medical University,Department of Medical Oncology
[7] Fudan University Shanghai Cancer Center,undefined
[8] Shanghai Fengxian District Central Hospital,undefined
来源：
Breast Cancer Research and Treatment | 2018年 / 168卷
关键词：
GnRHa; Ovarian preservation; Breast cancer; Premenopausal; ER-positive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：679 / 686
页数：7
相关论文
共 15 条
  • [1] Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival
    Zhang, Ying
    Ji, Yajie
    Li, Jianwei
    Lei, Li
    Wu, Siyu
    Zuo, Wenjia
    Jia, Xiaoqing
    Wang, Yujie
    Mo, Miao
    Zhang, Na
    Shen, Zhenzhou
    Wu, Jiong
    Shao, Zhimin
    Liu, Guangyu
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 679 - 686
  • [2] Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
    Lambertini, Matteo
    Richard, Francois
    Nguyen, Bastien
    Viglietti, Giulia
    Villarreal-Garza, Cynthia
    CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH, 2019, 13
  • [3] Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients
    Vanhuyse, M
    Fournier, C
    Bonneterre, J
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1283 - 1288
  • [4] Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
    Lee, Dong-Yun
    Park, Yeon Hee
    Lee, Jeong Eon
    Choi, DooSeok
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (03) : 649 - 656
  • [5] Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
    Dong-Yun Lee
    Yeon Hee Park
    Jeong Eon Lee
    DooSeok Choi
    Breast Cancer Research and Treatment, 2018, 171 : 649 - 656
  • [6] Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
    Yukinori Ozaki
    Yuko Tanabe
    Nobuko Tamura
    Takuya Ogura
    Chihiro Kondoh
    Yuji Miura
    Kenichi Yoshimura
    Hidetaka Kawabata
    Toshimi Takano
    Breast Cancer, 2018, 25 : 343 - 349
  • [7] Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
    Ozaki, Yukinori
    Tanabe, Yuko
    Tamura, Nobuko
    Ogura, Takuya
    Kondoh, Chihiro
    Miura, Yuji
    Yoshimura, Kenichi
    Kawabata, Hidetaka
    Takano, Toshimi
    BREAST CANCER, 2018, 25 (03) : 343 - 349
  • [8] Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study
    Chen, Yifei
    Zhang, Ruyan
    Yan, Ying
    Li, Huiping
    Song, Guohong
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (03) : 543 - 550
  • [9] Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients
    Lee, Dong-Yun
    Kim, Ji-Yeon
    Yu, Jonghan
    Kim, Seok Won
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis
    Vitek, Wendy S.
    Shayne, Michelle
    Hoeger, Kathleen
    Han, Yu
    Messing, Susan
    Fung, Chunkit
    FERTILITY AND STERILITY, 2014, 102 (03) : 808 - U525
12